| Are European clinical trial funders policies on clinical trial registration and reporting improving? A cross-sectional study M O’Riordan, M Haslberger, C Cruz, T Suljic, M Ringsten, T Bruckner Journal of Clinical and Translational Science 7 (1), e166, 2023 | 5 | 2023 |
| Preclinical efficacy in investigator's brochures: Stakeholders' views on measures to improve completeness and robustness M Haslberger, SG Schorr, D Strech, T Haven British Journal of Clinical Pharmacology 89 (1), 340-350, 2023 | 5 | 2023 |
| Reporting of retrospective registration in clinical trial publications: a cross-sectional study of German trials M Haslberger, S Gestrich, D Strech BMJ open 13 (4), e069553, 2023 | 4 | 2023 |
| Frequency of multiple changes to prespecified primary outcomes of clinical trials completed between 2009 and 2017 in German university medical centers: A meta-research study M Holst, M Haslberger, S Yerunkar, D Strech, LG Hemkens, BG Carlisle Plos Medicine 20 (10), e1004306, 2023 | 2 | 2023 |
| Multivariable prediction models for health care spending using machine learning: a protocol of a systematic review AW Huang, M Haslberger, N Coulibaly, O Galárraga, A Oganisian, ... Diagnostic and Prognostic Research 6 (1), 4, 2022 | 2 | 2022 |
| Hidden changes to prespecified primary outcomes of clinical trials completed between 2009 and 2017 in German University Medical Centres: A meta-research study MR Holst, M Haslberger, S Yerunkar, D Strech, LG Hemkens, BG Carlisle medRxiv, 2023.02. 20.23286182, 2023 | | 2023 |
| A systematic mapping and bibliometric analysis of systematic reviews of health economic evaluations: A protocol M Haslberger, L Martinez-Gamboa, JPA Ioannidis, T Mathes, L Belbasis | | 2022 |
| Meta-research on systematic reviews of cost-effectiveness analyses M Haslberger, T Mathes, L Belbasis OSF, 2022 | | 2022 |
Daniel StrechCharité - Universitätsmedizin Berlin; QUEST Center, Berlin Institute of Health (BIH)Bestätigte E-Mail-Adresse bei charite.de
